The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy

Gopalakrishnan, Vancheswaran, Helmink, Beth A., Spencer, Christine N., Reuben, Alexandre, Wargo, Jennifer A.·2018·Cancer Cell

Cited by (1,000)

Items 701–800 of 1,000

  1. The Role of Intestinal Flora in Anti-Tumor Antibiotic Therapy
    Xuewei Ye, Anqi Wang, Wenting Lin, Yiwen Xu, Xinyi Dong, Yue Zhou, Kewei Tian, Xiaoling Xu · 2022 · Frontiers in Bioscience-Landmark
  2. Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer
    Precious Mathebela, Botle Precious Damane, Thanyani Victor Mulaudzi, Zilungile L. Mkhize‐Kwitshana, Guy Roger Gaudji, Zodwa Dlamini · 2022 · International Journal of Molecular Sciences
  3. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis
    Zhenglei Shen, Xuezhong Gu, Honghua Cao, Wenwen Mao, Linlin Yang, Min Yi He, Rui Zhang, Yeying Zhou, Kunmei Liu, Lilan Wang et al. · 2021 · International Microbiology
  4. Gut-eye axis
    Weixin Zheng, Mingzhi Su, Ningxi Hong, Panpan Ye · 2025 · Advances in Ophthalmology Practice and Research
  5. Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer
    Travis T. Sims, Greyson W. G. Biegert, Doreen Ramogola‐Masire, Kebatshabile Ngoni, Travis N. Solley, Matthew Stephen Ning, Molly Blue El Alam, Melissa Paola Mezzari, Joseph F. Petrosino, Nicola M. Zetola et al. · 2020 · International Journal of Gynecological Cancer
  6. Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
    Enzo Spisni, Silvia Turroni, Patrizia Alvisi, Renato Spigarelli, Demetrio Azzinnari, Dario Ayala, Veronica Imbesi, Maria Chiara Valerii · 2022 · Frontiers in Pharmacology
  7. Caulobacter and Novosphingobium in tumor tissues are associated with colorectal cancer outcomes
    Bin Zhou, Linli Shi, Min Jin, Mingxia Cheng, Dandan Yu, Lei Zhao, Jieying Zhang, Chang Yu, Tao� Zhang, Hongli Liu · 2023 · Frontiers in Oncology
  8. The colorectal cancer-specific microbiome regulation and immune response activation via an artificial biomimetic nanovaccine
    Xiaoduan Zhuang, Bang Li, Xiaoyan Liu, Tingting Fan, Xinyue Lan, Xinying Wang, Meng Yu · 2023 · Chemical Engineering Journal
  9. From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer
    Yongwoo David Seo, Jennifer Ann Wargo · 2023 · Cell Reports Medicine
  10. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities
    Pratibha Pandey, Fahad Khan · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
  11. A new strategy for treating colorectal cancer: Regulating the influence of intestinal flora and oncolytic virus on interferon
    Jia Yi, Peizhe Lin, Qingbo Li, Ao Zhang, Xianbin Kong · 2023 · Molecular Therapy — Oncolytics
  12. Dissecting the association between gut microbiota and liver cancer in European and East Asian populations using Mendelian randomization analysis
    Hua Jiang, Tianjun Song, Zhongyi Li, Lingxuan An, Chiyi He, Kai Zheng · 2023 · Frontiers in Microbiology
  13. Drug and gut microbe relationships: Moving beyond antibiotics
    Shreyas V. Kumbhare, Inti Pedroso, Juan Antonio Ugalde, Valeria Márquez‐Miranda, Ranjan Sinha, Daniel Eduardo Almonacid · 2023 · Drug Discovery Today
  14. Microbiota as a New Target in Cancer Pathogenesis and Treatment
    A. Algrafi, Aisha A Jamal, Dana M Ismaeel · 2023 · Cureus
  15. Nanocatalytic Anti‐Tumor Immune Regulation
    Mingyuan Li, Han Jiang, Ping Hu, Jianlin Shi · 2024 · Angewandte Chemie
  16. Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis
    Yinghui Chai, Xin Liu, Guangliang Bai, Nannan Zhou, Danfeng Liu, Xiaomeng Zhang, Min Li, Kang Li, Hong Lei · 2024 · Frontiers in Immunology
  17. Concomitant Medications Alter Clinical Outcomes in Patients with Advanced Digestive Tract Cancer Receiving PD-1 Checkpoint Inhibitors Combined with Antiangiogenetic Agents
    Yiran Wang, Zhiheng Wu, Xudong Zhu, Yu Zheng, Yanyan Yang, Jinming Tu, Hongming Pan, Xian Zhong, Weidong Han, Junlin Yao · 2024 · Journal of Gastrointestinal Cancer
  18. Gastrointestinal Cancer Patient Derived Organoids at the Frontier of Personalized Medicine and Drug Screening
    Zhenjie Yang, Jun Qing Yu, Chi Chun Wong · 2024 · Cells
  19. Decoding the secret of extracellular vesicles in the immune tumor microenvironment of the glioblastoma: on the border of kingdoms
    Bouchra Ghazi, Zakia Harmak, Mounir Rghioui, Abdou-samad Kone, Adil El Ghanmi, Abdallah Badou · 2024 · Frontiers in Immunology
  20. Chrysophanol: A promising natural compound in cancer therapy – Mechanistic insights and future perspectives
    Dehong Liu, Kun Zhu, Tao Guo, Yao Xiao, Meijing Wang, Yanxin Guan, Junjun Li, Degui Chang, Xujun Yu · 2024 · Pharmacological Research
  21. Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma
    Alexander C. Chacon, Alexa D. Melucci, Shuyang S. Qin, Peter A. Prieto · 2021 · International Journal of Molecular Sciences
  22. Effect ofHelicobacter pylorion immunotherapy is gaining more attention
    Yanyan Shi, Huiling Zheng, Zhijun Guo, Ruiyi Deng, Wei Yu, Yahan Song, Shigang Ding · 2022 · Helicobacter
  23. Amaryllidaceae Alkaloids Decrease the Proliferation, Invasion, and Secretion of Clinically Relevant Cytokines by Cultured Human Colon Cancer Cells
    Véronique Mathieu, Breana Laguera, Marco Masi, S. Dulanto, Tanner W. Bingham, Lucas W. Hernandez, David Šarlah, Antonio Evidente, Denis L. J. Lafontaine, Alexander Kornienko et al. · 2022 · Biomolecules
  24. The human and animals’ malignant melanoma: comparative tumor models and the role of microbiome in dogs and humans
    Catarina Alves Pinto, Catarina Aluai‐Cunha, Andreia Alexandra Ferreira Santos · 2023 · Melanoma Research
  25. Breast cancers as ecosystems: a metabolic perspective
    Flavia Martino, Mariadomenica Lupi, Enrico Giraudo, Letizia Lanzetti · 2023 · Cellular and Molecular Life Sciences
  26. Stressing Out about Cancer Immunotherapy
    Xue‐Yan He, David Chee‐Eng Ng, Linda Van Aelst, Mikala Egeblad · 2019 · Cancer Cell
  27. Low dose antibiotic ingestion potentiates systemic and microbiome changes induced by silver nanoparticles
    Matthew J. Meier, Kathy C. Nguyen, Jennifer Crosthwait, Alice Kawata, Marc D. Rigden, Karen Leingartner, A. Wong, Alison C. Holloway, Philip S. Shwed, Lee A. Beaudette et al. · 2021 · NanoImpact
  28. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?
    Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, Bartosz Kamil Sobocki, Karol Połom, Luigi Marano, Leszek Kalinowski, Karolina Skonieczna‐Żydecka · 2023 · Gut Microbes
  29. Role of the intestinal microbiota and diet in the onset and progression of colorectal and breast cancers and the interconnection between both types of tumours
    Sergio Ruiz-Saavedra, Aida Zapico, Sónia González, Nuria Salazar, Clara G. de los Reyes‐Gavilán · 2023 · Microbiome Research Reports
  30. The role of intestinal flora on tumor immunotherapy: recent progress and treatment implications
    Yimin Zhou, Xiangdong Liu, Wei Gao, Xin Luo, Junying Lv, Yunshan Wang, Duanrui Liu · 2023 · Heliyon
  31. Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study
    Jia Li, Xuedi Gao, Xiaoming Sun, Hao Li, Jiaheng Wei, Lin Li Lv, Liangming Zhu · 2024 · BMC Cancer
  32. Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma
    Zikun Yu, Qin Wang, Zimeng Wang, Sihan Liu, Tianliang Xia, Chongyang Duan, You‐Ping Liu, Xi Ding, Siyuan Chen, Tao Yu et al. · 2024 · Head & Neck
  33. Correlation of gut microbial diversity to sight-threatening diabetic retinopathy
    Rehana Khan, Abhishek Sharma, Raghul Ravikumar, Ronnie Jacob George, Sobha Sivaprasad, Rajiv Raman · 2024 · BMC Microbiology
  34. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut
    Khalid El Bairi, Rachid Jabi, Dario Trapani, Hanae Boutallaka, Bouchra Ouled Amar Bencheikh, Mohammed Bouziane, M. Amrani, Saïd Afqir, Adil Maleb · 2020 · Expert Review of Clinical Pharmacology
  35. A Screening Model for Probiotics Against Specific Metabolic Diseases Based on Caco-2 Monolayer Membrane
    Yang Liu, Peng Jiang, Shiya Zhu, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai · 2022 · Engineering
  36. Global trends and hotspots of gastrointestinal microbiome and toxicity based on bibliometrics
    Jiajia Duan, Chuanxin Liu, Xiaoyang Bai, Xiaoying Zhao, Tao Jiang · 2023 · Frontiers in Microbiology
  37. Systems biology in inflammatory bowel diseases: on the way to precision medicine
    Nikolas Dovrolis · 2019 · Annals of Gastroenterology
  38. Using Conditional Generative Adversarial Networks to Boost the Performance of Machine Learning in Microbiome Datasets
    Derek J. Reiman, Yang David Dai · 2020 · International Conference on Deep Learning Theory and Applications (DeLTA)
  39. Modeling the effect of gut microbiome on therapeutic efficacy of immune checkpoint inhibitors against cancer
    Yu Chen, Xiulan Lai · 2022 · Mathematical Biosciences
  40. Microbiome Profile of Dogs with Stage IV Multicentric Lymphoma: A Pilot Study
    Feriel Yasmine Mahiddine, Inhwan You, Heekee Park, Min Jung Kim · 2022 · Veterinary Sciences
  41. Indole-3-propionic acid links gut dysfunction to diabetic retinopathy: a biomarker and novel therapeutic approach
    Ram Prasad, Yvonne Adu-Agyeiwaah, Borhane Eddine Chérif Ziani, Jason L. Floyd, Edgar L. Ready, Sarbodeep Paul, Fadeela Sheini, Rati Sharma, Robert F. Rosencrans, Sergio Li Calzi et al. · 2025 · Gut
  42. Exploring the intricate link between gut microbiota dysbiosis and the aging process: implications for age-related diseases
    Hanin M. Abahussin, Maryam S. Alotaibi, Othman A. Alhazzaa, Aminah G. Alotaibi, Sarah M. Alsaab, Nora Aljawini, Abdullah O. Alawad · 2025 · Gut Pathogens
  43. The underexplored links between cancer and the internal body climate: Implications for cancer prevention and treatment
    Doru Paul, Aurora M. Nedelcu · 2022 · Frontiers in Oncology
  44. Current landscape and tailored management of immune-related adverse events
    Wenhui Liu, Zhiying Luo, Yiping Liu, Bao Sun · 2023 · Frontiers in Pharmacology
  45. Nanoplatform-Mediated Autophagy Regulation and Combined Anti-Tumor Therapy for Resistant Tumors
    Caixia Yang, Yuan Ding, Zhengwei Mao, Weilin Wang · 2024 · International Journal of Nanomedicine
  46. Reversal of Platinum-based Chemotherapy Resistance in Ovarian Cancer by Naringin Through Modulation of The Gut Microbiota in a Humanized Nude Mouse Model
    Bingqing Xie, Xiaoni Zhou, Chuanlin Luo, Yilin Fang, Yufei Wang, Jing Wei, Liping Cai, Tingtao Chen · 2024 · Journal of Cancer
  47. Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives
    Ari Hashimoto, Shigeru Hashimoto · 2024 · Cancers
  48. Metagenomics and Non‐Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non‐Small Cell Lung Cancer
    Chen‐Guang Liu, Meixi Lin, Yu Xin, Man Sun, Jia Cui, Dan Liu, Dan Zang, Jun Chen · 2025 · Thoracic Cancer
  49. Gut microbiome and colorectal cancer: From pathogenesis to treatment
    Masoud Lahouty, Manouchehr Fadaee, Reza Aghaei, Fatemeh Alizadeh, Amirmohammad Jafari, Yaeghob Sharifi · 2025 · Pathology - Research and Practice
  50. What can the gut microbiome teach us about the connections between child physical and mental health? A systematic review
    Janice M. Kan, Caitlin S.M. Cowan, Chee Yee Ooi, Nadine Angele Kasparian · 2019 · Developmental Psychobiology
  51. “Right-to-Try” experimental drugs: an overview
    Vijay Mahant · 2020 · Journal of Translational Medicine
  52. Metaheuristics and Pontryagin’s minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparison
    Sima Sarv Ahrabi, Alireza Momenzadeh · 2020 · Journal of Mathematical Biology
  53. Non-immune Cell Components in the Gastrointestinal Tumor Microenvironment Influencing Tumor Immunotherapy
    Zhengshuo Li, Xiaoyue Zhang, Can Liu, Jian Ma · 2021 · Frontiers in Cell and Developmental Biology
  54. Vaginal microbiome in patients with menstrual cycle disorders (review)
    Lebedeva Op, Грязнова, М. В., Olesya N. Kozarenko, Сыромятников, М. Ю., Vasily N. Popov · 2021 · RESEARCH RESULTS IN BIOMEDICINE
  55. Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant
    Hon Jen Wong, Wen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, Glenn Kunnath Bonney, Alfred Wei Chieh Kow, Daniel Q. Huang, Mohammad Shadab Siddiqui, Mazen Noureddin, Nicholas L. X. Syn et al. · 2022 · Frontiers in Medicine
  56. Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ
    Ilaria Roato, Lorenzo Pavone, Riccardo Pedraza, Ilaria Bosso, Giacomo Baima, Francesco Maria Erovigni, Federico Davide Mussano · 2023 · Cells
  57. Characterizing the Native Microbiome Using Next-Generation Sequencing of Bilateral ‘Aseptic’ Knees
    Tracy M. Borsinger, Michael T. Torchia, Bethany S. Malskis, Benjamin A. Levy, Paul M. Werth, Wayne E. Moschetti · 2023 · The Journal of Arthroplasty
  58. Mendelian randomization analysis to investigate the gut microbiome in oral and oropharyngeal cancer
    Qihe Zhang, Huanhuan Wang, Yuan Tian, Jinjie Li, Ying Xin, Xin Mei Jiang · 2024 · Frontiers in Cellular and Infection Microbiology
  59. Microbiome and its implications in oncogenesis: a Mendelian randomization perspective.
    Kexin Feng, Fei Ren, Zeyu Xing, Yifan Zhao, Chenxuan Yang, Jiaxiang Liu, Qingyao Shang, Xin Wang, Xiang Wang · 2023 · PubMed Central
  60. Gut Microbiome and the Response to Immunotherapy in Cancer
    Andreea Lucia Stancu · 2018 · Discoveries
  61. Patient-derived cancer modeling for precision medicine in colorectal cancer: beyond the cancer cell line
    Dae Hee Pyo, Hye Kyung Hong, Woo Yong Lee, Yong Beom Cho · 2020 · Cancer Biology & Therapy
  62. Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
    Yilun Liu, Zhongmin Li, Yuanyu Wu, Xiabin Jing, Lin Li, Xuedong Fang · 2021 · Frontiers in Immunology
  63. Role of gut microbiome in the outcome of cancer immunotherapy
    Junting Ma, Wenwen Zhu, Beixing Liu · 2021 · International Journal of Cancer
  64. Commensal microbiota in the digestive tract: a review of its roles in carcinogenesis and radiotherapy
    Jiali Dong, Yuan Li, Huiwen Xiao, Ming Cui, Saijun Fan · 2021 · Cancer Biology and Medicine
  65. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
    Michela Roberto, Catia Carconi, Micaela Cerreti, Francesca Matilde Schipilliti, Andrea Botticelli, Federica Mazzuca, Paolo Marchetti · 2021 · Frontiers in Immunology
  66. Antibiotics and proton pump inhibitors suppress the efficacy of immunotherapy against non‐small cell lung cancer
    Xiayao Diao · 2020 · Thoracic Cancer
  67. Environmental Impact on Metabolism
    Giovanna Muscogiuri, Luigi Barrea, Evelyn Frías-Toral, Eloisa Garcia-Velasquez, Cristina de Angelis, Carlos Ordóñez, Gabriela Cucalón, Marwan El Ghoch, Annamaria Colao, Rosario Pivonello · 2023 · Endocrinology
  68. Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions
    Valentina Cossiga, Maria Guarino, Mario Capasso, Filomena Morisco · 2023 · Cells
  69. Facts and Hopes in Colorectal Cancer Immunotherapy
    Michael Bonner Foote, Guillem Argilés, Benoı̂t Rousseau, Neil Howard Segal · 2023 · Clinical Cancer Research
  70. Impact of Gut Microbiota on Lymphoma: New Frontiers in Cancer Research
    Sabri Saeed Sanabani · 2024 · Clinical Lymphoma Myeloma & Leukemia
  71. Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer
    Makoto Sono, Kei Iimori, Munemasa Nagao, Satoshi Ogawa, Takahisa Maruno, Yuki Nakanishi, Takayuki Anazawa, Kazuyuki Nagai, Toshihiko Masui, Hiroshi Mori et al. · 2024 · Pancreatology
  72. Immunomodulatory Properties of Multi-Strain Postbiotics on Human CD14+ Monocytes
    Kyle D. Roberts, S. Ansar Ahmed, Erin Marie D. San Valentin, Luca Di Martino, Thomas S. McCormick, Mahmoud Afif Ghannoum · 2024 · Life
  73. Peritoneal fluid microbiota profile of patients with deep endometriosis
    Helena Malvezzi, Bruna Azevedo Cestari, Helen Mendes, Camila Hernandes, Sérgio Podgaec · 2024 · Microbial Pathogenesis
  74. Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles
    Yibo Xian, Zhipeng Chen, Zhou Lan, Chenchen Zhang, Hao Sun, Zhenzhen Liu, Ping Kong, Yajun Liang, Yingying Zhao, Si‐Yang Maggie Liu et al. · 2025 · Gut Microbes
  75. Examining the impact of the microbiome on cancer immunotherapy outcomes: A review
    Ayushi Ahlawat, Sunny Chauhan, Ishika Antil, Sudhanshu Kumar Jha, Vitthal G. Huddar · 2025 · Ayush journal of integrative oncology.
  76. Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy
    Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, Spartaco Santi, Andrea Caporali, Domenico D’Arca · 2023 · Cancers
  77. The role of intermittent fasting and the ketogenic diet in cancer disease: can they replace the Mediterranean diet?
    Aleyna Nur Küçük, Seda Çiftçi · 2023 · European Journal of Cancer Prevention
  78. The Cytotoxic and Anti-tumor Potential of Methanolic Extracts of Indian Marine Isolates in HCT116 Colorectal Cancer Cells
    Shahjahan A, Sruthi Sekar, Kumaran Kasinathan, Kandasamy Nagarajan ArulJothi · 2023 · Anti-Cancer Agents in Medicinal Chemistry
  79. The Causal Relationship between the Morning Chronotype and the Gut Microbiota: A Bidirectional Two-Sample Mendelian Randomization Study
    Manman Chen, Zhenghe Wang, Din Son Tan, Xijie Wang, Zichen Ye, Zhilan Xie, Daqian Zhang, Dandan Wu, Yuankai Zhao, Yimin Qu et al. · 2023 · Nutrients
  80. Use of an Extremely Biodiverse Probiotic and a Supplement Based on Microbial Chondroitin Sulfate is Associated with a Significant Decrease of Serum Free Kappa Light Chains as well as a Trend Toward Normalization of Kappa/Lambda Ratio and of Plasma Cell Bone Marrow Infiltration in a Case of Multiple Myeloma
    Nicola Antonucci, Stefania Pacini, Marco Ruggiero · 2019 · American Journal of Immunology
  81. Germinal immunogenetics as a predictive factor for immunotherapy
    Sadal Refae, Jocelyn Gal, Patrick Brest, Gerard Alain Milano · 2019 · Critical Reviews in Oncology/Hematology
  82. Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab
    Huezin H. Lim, Ashley Mark Hopkins, Andrew Rowland, Hoi-Yee Yuen, Christos Stelios Karapetis, Michael Joseph Sorich · 2019 · Targeted Oncology
  83. GraphKKE: graph Kernel Koopman embedding for human microbiome analysis
    Kateryna Melnyk, Stefan Klus, Grégoire Montavon, Tim O. F. Conrad · 2020 · Applied Network Science
  84. GraphKKE: graph Kernel Koopman embedding for human microbiome analysis
    Kateryna Melnyk, Stefan Klus, Grégoire Montavon, Tim Conrad · 2020 · Refubium (Universitätsbibliothek der Freien Universität Berlin)
  85. Mining the Gut Microbiota for Microbial-Based Therapeutic Strategies in Cancer Immunotherapy
    Bolei Li, Tao Gong, Yu Hao, Xuedong Zhou, Lei Cheng · 2021 · Frontiers in Oncology
  86. A Simultaneous Feature Selection and Compositional Association Test for Detecting Sparse Associations in High-Dimensional Metagenomic Data
    Andrew L. Hinton, Peter J. Mucha · 2022 · Frontiers in Microbiology
  87. Small Extracellular Vesicles: Key Forces Mediating the Development and Metastasis of Colorectal Cancer
    Wenjie Zhang, Xiaoxue Hu, Zhengting Jiang · 2022 · Cells
  88. Inborn errors of immunity and related microbiome
    Raja Hazime, Fatima-Ezzohra Eddehbi, Saad Elmojadili, Nadia Lakhouaja, Ikram Souli, Abdelmouïne Salami, Bouchra M’raouni, Imane Brahim, Mohamed Oujidi, Morad Guennouni et al. · 2022 · Frontiers in Immunology
  89. Colorectal Cancer and the Role of the Gut Microbiota—Do Medical Students Know More Than Other Young People?—Cross-Sectional Study
    Paulina Helisz, Grzegorz Dziubanek, Karolina Helena Krupa-Kotara, Weronika Gwioździk, Mateusz Krystian Grajek, Joanna Głogowska‐Ligus · 2022 · Nutrients
  90. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data
    Wontack Han, Yuzhen Ye · 2018 · Pacific Symposium on Biocomputing (PSB)
  91. [Therapeutic Relevance of Human Microbiota and Lung Cancer].
    Huijie Zhou, Jiaojiao Suo, Jiang Zhu · 2019 · Europe PMC (PubMed Central)
  92. Immunotherapy in Non-Small-Cell Lung Cancer: from Targeted Molecules to Resistance Patterns
    Sylvie Brassart‐Pasco, Véronique Dalstein, Bertrand Brassart, Maxime Dewolf, Christine Clavel, Jean‐Baptiste Oudart · 2020 · Pharmacogenomics
  93. Compassionate use of others’ immunity — understanding gut microbiome in Covid-19
    Prashanth Thalanayar Muthukrishnan, Robert T. FAILLACE · 2020 · Critical Care
  94. Lactic acid bacteria fermented foods: Impact on immune system and consequences over type 2 diabetes mellitus
    Rahnuma Ahmad, Oli Angus Nnamdi, Ayukafangha Etando, Paras Sharma, Susmita Sinha, Kona Chowdhury, Adekunle Babajide Rowaiye, Salma Akter, Taslin Jahan Mou, Sameer Dhingra et al. · 2023 · Journal of Applied Pharmaceutical Science
  95. Gut microbial signatures are associated with Lynch syndrome (LS) and cancer history in Druze communities in Israel
    Rawi Naddaf, Shaqed Carasso, Gili Reznick Levi, Erez Hasnis, Amalfi Qarawani, Itay Maza, Tal Gefen, Elizabeth Half, Naama Geva‐Zatorsky · 2023 · Scientific Reports
  96. The Potential of Clostridium butyricum to Preserve Gut Health, and to Mitigate Non-AIDS Comorbidities in People Living with HIV
    Qiyu Yang, Silvère D. Zaongo, Lijiao Zhu, Jiangyu Yan, Jiadan Yang, Jing Ouyang · 2024 · Probiotics and Antimicrobial Proteins
  97. Microbiome in cancer: A comparative analysis between humans and dogs
    Filippo Dell’Anno, Lisa Guardone, Valeria Listorti, Elisabetta Razzuoli · 2024 · The Veterinary Journal
  98. The Gut Microbiome in Aging and Ovarian Cancer
    Gena M. Dominique, Catherine Hammond, Mary Sharon Stack · 2024 · Aging and Cancer
  99. Tumor-colonizing Pseudoalteromonas elyakovii metabolically reprograms the tumor microenvironment and promotes breast ductal carcinoma
    Shuyan Liu, Youpeng Pan, Chaopeng Zheng, Qinghui Zheng, Yaoqiang Du, Yajuan Zheng, Hongchao Tang, Xiaozhen Liu, Jiancheng Mou, Xin Ying Zeng et al. · 2025 · mBio
  100. Investigating postbiotics as innovative adjuvants: deciphering the gut-breast connection in breast Cancer therapy, from gut microbiome to personalized medicine
    Rashmi Ghosh, Debayan Sil, Rohit R. Sharma, Dinesh Kumar, Kumari Komal, Sourabh Kumar, Hitendra Shaligram Mahajan, Manu Sharma, Manish Kumar · 2025 · Molecular Biology Reports